SN BioScience

About:

SN BioScience is developing cutting-edge platform technology.

Top Investors: TIPS Program, Smilegate Investment, SL Investment, Daekyo Investment, Comes Investment

Description:

SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA), peptide and protein to deliver in the form of nano-micelle, nanoparticle or liposome. Their proprietary “double core-shell technology” and pool of acceptable lipids and polymers could help your research that having difficulties in solubility or delivery.

Total Funding Amount:

$6.74M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2017-05-01

Contact Email:

snbs(AT)snbioscience.com

Founders:

Younghwan Park

Number of Employees:

11-50

Last Funding Date:

2020-07-02

IPO Status:

Private

Industries: